Sackler family to pay up to $7 billion cash under Purdue Pharma's new opioid settlement plan
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family who own the company pay up to $7 billion.
The settlement includes a $100 million payment as soon as it gets the go-ahead from a judge, plus six annual payments of $50 million between 2022 and 2027. The final balance will be due in ...
At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...
North Carolina was among 15 states to reach the $7.4 billion settlement in January with Purdue Pharma and its owners, the ...
In 2022, the state started receiving proceeds negotiated through the National Opioid Settlement with pharmaceutical companies. With $980 million due to come to Indiana over 18 years, the Indiana ...
How is this possible? Well Purdue was facing trillions in claims over its role in the opioid crisis, which has killed more than 800,000 Americans. Purdue, and its wealthy owners, members of the ...
To address a budget deficit last year, Governor Katie Hobbs and Republicans struck a deal to dip into the $1.14 billion of the opioid settlement fund and allocated more than $100 million dollars ...
A bill proposed in this year’s Maryland General Assembly would require more transparency with how local government agencies spend money received from opioid case settlements. The Senate’s ...
Some counties, Hamilton County Mayor Weston Wamp said of unrestricted funds received from state settlements in opioid-related lawsuits, drop the money into their general fund.
At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback